Menu Menu

IPA    Immunoprecise Antibodies Ltd    1715925    
Income Statement
Revenue press_release_mar_13_202 6,125,000
Net Income press_release_mar_13_202 -2,553,000
Profit Margin -41.68%

Balance Sheet
Current Assets 12,502,000
Assets 59,963,000
Current Liabilities 12,409,000
Liabilities 27,286,000
Equity 32,677,000

Cash Flow Statement
Operating Cash Flow -4,067,000
Investing Cash Flow -328,000

Market Analysis
BVPS 1.21
PB 0.35
PS 1.25
FCF -4,395,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/14 0.51
Apr May Jun
Jul Aug Sep
7/29 9/16 -0.15
Oct Nov Dec
12/12

Find a discrepancy? The most accurate way to find company fundamental data is to view IPA documents filed with the SEC.


IPA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas